Bank of America’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.5M | Buy |
573,282
+268,356
| +88% | +$7.72M | ﹤0.01% | 2381 |
|
|
2025
Q1 | $10.2M | Buy |
304,926
+69,645
| +30% | +$2.34M | ﹤0.01% | 2653 |
|
|
2024
Q4 | $12M | Sell |
235,281
-42,792
| -15% | -$2.19M | ﹤0.01% | 2348 |
|
|
2024
Q3 | $14.2M | Sell |
278,073
-27,096
| -9% | -$1.38M | ﹤0.01% | 2349 |
|
|
2024
Q2 | $13.7M | Sell |
305,169
-51,973
| -15% | -$2.33M | ﹤0.01% | 2285 |
|
|
2024
Q1 | $16.7M | Buy |
357,142
+12,729
| +4% | +$596K | ﹤0.01% | 2125 |
|
|
2023
Q4 | $12.3M | Buy |
344,413
+189,513
| +122% | +$6.74M | ﹤0.01% | 2221 |
|
|
2023
Q3 | $4.61M | Buy |
154,900
+34,526
| +29% | +$1.03M | ﹤0.01% | 2910 |
|
|
2023
Q2 | $2.17M | Sell |
120,374
-56,099
| -32% | -$1.01M | ﹤0.01% | 3501 |
|
|
2023
Q1 | $2.83M | Buy |
176,473
+52,406
| +42% | +$842K | ﹤0.01% | 3459 |
|
|
2022
Q4 | $2.27M | Buy |
124,067
+64,610
| +109% | +$1.18M | ﹤0.01% | 3566 |
|
|
2022
Q3 | $1.17M | Buy |
59,457
+5,171
| +10% | +$102K | ﹤0.01% | 4075 |
|
|
2022
Q2 | $1.01M | Sell |
54,286
-43,648
| -45% | -$814K | ﹤0.01% | 4234 |
|
|
2022
Q1 | $2.15M | Buy |
97,934
+29,837
| +44% | +$655K | ﹤0.01% | 3919 |
|
|
2021
Q4 | $1.94M | Buy |
68,097
+56,475
| +486% | +$1.6M | ﹤0.01% | 3938 |
|
|
2021
Q3 | $245K | Sell |
11,622
-1,487
| -11% | -$31.3K | ﹤0.01% | 5335 |
|
|
2021
Q2 | $247K | Buy |
13,109
+789
| +6% | +$14.9K | ﹤0.01% | 5191 |
|
|
2021
Q1 | $188K | Sell |
12,320
-7,000
| -36% | -$107K | ﹤0.01% | 5427 |
|
|
2020
Q4 | $272K | Sell |
19,320
-1,000
| -5% | -$14.1K | ﹤0.01% | 4690 |
|
|
2020
Q3 | $318K | Sell |
20,320
-514
| -2% | -$8.04K | ﹤0.01% | 4435 |
|
|
2020
Q2 | $365K | Buy |
20,834
+11,398
| +121% | +$200K | ﹤0.01% | 4331 |
|
|
2020
Q1 | $139K | Sell |
9,436
-3,562
| -27% | -$52.5K | ﹤0.01% | 4750 |
|
|
2019
Q4 | $326K | Buy |
12,998
+1,690
| +15% | +$42.4K | ﹤0.01% | 4561 |
|
|
2019
Q3 | $170K | Sell |
11,308
-1,305
| -10% | -$19.6K | ﹤0.01% | 4973 |
|
|
2019
Q2 | $316K | Sell |
12,613
-17,331
| -58% | -$434K | ﹤0.01% | 4651 |
|
|
2019
Q1 | $682K | Buy |
29,944
+24,012
| +405% | +$547K | ﹤0.01% | 4143 |
|
|
2018
Q4 | $179K | Buy |
5,932
+4,689
| +377% | +$141K | ﹤0.01% | 4871 |
|
|
2018
Q3 | $36K | Buy |
+1,243
| New | +$36K | ﹤0.01% | 5590 |
|